Board Unveils New Foresight and Signals Products: Revolutionizing Business Planning with AI and Economic Intelligence
19.2.2025 15:00:00 CET | Business Wire | Press release
Board, the leading Enterprise Planning Platform, is transforming the way businesses anticipate and adapt to economic shifts with today’s announcement of Board Foresight and Board Signals. These cutting-edge solutions, developed as a result of Board’s recent acquisition of Prevedere, empower enterprises with real-time economic indicators, predictive analytics, and the expertise of Board’s in-house economists—all backed by exclusive access to over 5 million global datasets.
This release marks a huge step forward in completing Board’s product vision. By harnessing the power of macroeconomic intelligence, the Board Enterprise Planning Platform now enables more comprehensive, collaborative, and continuous planning capabilities than ever before. Board Foresight and Signals give business leaders the ability to look beyond internal historical data, forecast with greater accuracy, scenario plan with more agility, and make strategic decisions with confidence in an increasingly volatile world.
Board Foresight: Continuous planning with external data, AI, and predictive analytics
Board Foresight takes business forecasting to the next level by unlocking the power of external data with expert-curated economic indicators, an advanced correlation engine, and predictive analytics. With real-time updates from millions of external sources, Board Foresight enables enterprises to anticipate market shifts, align business strategies and drive continuous planning.
Key benefits of Board Foresight:
- Expert-Curated Indicators: Get a list of the external factors most likely to impact your industry.
- Powerful Correlation Engine: Connect to your own internal time series data and Foresight will run millions of models to identify your most relevant performance drivers.
- Results Explained by AI: Get a complete understanding of the external factors impacting your business, with clear explanation and interpretation delivered through generative AI.
- Predictive Forecasting to Support Continuous Planning: Forecast with better accuracy and turn continuous planning into a competitive advantage.
Learn more at https://www.board.com/en/product/foresight.
Board Signals: Make smarter strategic decisions with expert-curated external data
Board Signals provides decision-makers with real-time, industry-specific economic indicators to help them navigate market volatility with confidence. Designed for strategic planners, executive officers, and board members, Board Signals delivers clear, actionable intelligence to drive smarter business decisions and is available today.
Key benefits of Board Signals:
- Industry-Specific Economic Intelligence: Get expert-curated indicators tailored to your industry, monitored and updated regularly by Board’s in-house economists.
- Smart Alerts on Market Volatility: Receive real-time alerts on headwinds and tailwinds impacting your business so you can respond in an agile manner to capitalize on opportunities and mitigate risks.
- Indicator Reports and Industry Outlook Score: Visualize economic conditions with intuitive reports and scoring to support strategic decision-making.
Learn more at https://www.board.com/en/product/signals.
An Innovative Breakthrough in Enterprise Planning
David Marmer, SVP of Product at Board, emphasized the significance of these new solutions:
“The introduction of Board Foresight and Board Signals marks a new beginning for enterprise planning. For too long, businesses have relied solely on historical internal data, missing the critical external factors that drive success or failure. With the power of over 5 million datasets, AI-driven analytics, and expert economic intelligence, our customers can now plan continuously for the future with greater confidence and precision. These innovations reflect Board’s commitment to giving our customers the tools they need to stay ahead.”
Visionary Brands are Leading the Way
Leading enterprises are already leveraging Board Signals and Board Foresight to enhance their decision-making. Milwaukee Tool, Whataburger, and Kraft Heinz are among the early adopters benefiting from these solutions, using them to navigate economic volatility, optimize inventory, and drive strategic growth.
“This has been a game-changer for Whataburger,” says Pete Valadez, Senior Director of Financial Planning & Analysis at Whataburger. “By incorporating external data and predictive analytics into our forecasting process, we’ve been able to dramatically improve our accuracy and avoid missed expectations. The real-time alerts and collaborative nature of the solution have empowered our entire team to make data-driven decisions with confidence.”
General Availability
Board Signals and Board Foresight are available now globally.
About Board
The Board Enterprise Planning Platform powers financial and operational planning for more than 2,000 organizations worldwide. Industry leaders trust Board to turn complex data into better decisions with AI, analytics, and tailor-made solutions for enterprise-grade challenges. Global brands including H&M, BASF, Burberry, Toyota, Coca-Cola, KPMG, and HSBC use Board to enhance workflows and strengthen their competitive edge. Founded in 1994, and now with 25 offices worldwide, Board is recognized by leading analysts including Gartner, IDC, and BARC.
For more information, visit www.board.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250219004034/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom